The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Management of High Blood Pressure in African Americans<subtitle>Consensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks</subtitle>
Open accessAbstract
The purpose of this consensus statement is to offer primary care providers (including physicians, nurse practitioners, and physician assistants) a practical, evidence-based clinical tool for achieving blood pressure goals in African American patients. The need for specific recommendations for African Americans is highlighted by compelling evidence of a higher prevalence of hypertension and poorer cardiovascular and renal outcomes in this group than in white Americans. African Americans have disturbingly higher rates of cardiovascular mortality, stroke, hypertension-related heart disease, congestive heart failure, type 2 diabetes mellitus, hypertensive nephropathy, and end-stage renal disease (ESRD).1,2
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,094
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure
Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., Bray, G. A., Vogt, T. M., Cutler, J. A., Windhauser, M. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361601 · Cited by 5,981
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440101 · Cited by 5,638
Physical Activity and Health: A Report of the Surgeon General: (525162010-001)
(1995) · PsycEXTRA Dataset · doi:10.1037/e525162010-001 · Cited by 5,479
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., Levin, T. N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1193 · Cited by 4,487
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
(1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,695
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108
Staessen, J. A., Fagard, R., Thijs, L., Celis, H., Arabidze, G. G., Birkenhäger, W. H., Bulpitt, C. J., de Leeuw, P. W., Dollery, C. T., Fletcher, A. E., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05381-6 · Cited by 2,989
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873
D'Agostino, R. B., Grundy, S., Sullivan, L. M., Wilson, P., & for the CHD Risk Prediction Group (2001) · JAMA · doi:10.1001/jama.286.2.180 · Cited by 2,108
Turner, R. D., & Holman, R. R. (1998) · Cited by 1,974
Køber, L., Torp-Pedersen, C., Carlsen, J. E., Bagger, H., Eliasen, P., Lyngborg, K., Videbæk, J., Cole, D. S., Auclert, L., Pauly, N. C., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512213332503 · Cited by 1,773
Blood Pressure and End-Stage Renal Disease in Men
Klag, M. J., Whelton, P. K., Randall, B. L., Neaton, J. D., Brancati, F. L., Ford, C. E., Shulman, N. B., & Stamler, J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601043340103 · Cited by 1,663
Lindholm, L. H., Ibsen, H., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S. E., Kristiansson, K., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08090-x · Cited by 1,560
Krauss, R. M., Eckel, R. H., Howard, B., Appel, L. J., Daniels, S. R., Deckelbaum, R. J., Erdman, J. W., Kris-Etherton, P., Goldberg, I. J., Kotchen, T. A., et al. (2000) · Circulation · doi:10.1161/01.cir.102.18.2284 · Cited by 1,458
Hansson, L., Lindholm, L. H., Ekbom, T., Dahlöf, B., Lanke, J., Scherstén, B., Wester, P.-O., Hedner, T., & de Faire, U. (1999) · The Lancet · doi:10.1016/s0140-6736(99)10327-1 · Cited by 1,447
Preserving renal function in adults with hypertension and diabetes: A consensus approach
Bakris, G. L., Williams, M., Dworkin, L., Elliott, W. J., Epstein, M., Toto, R., Tuttle, K., Douglas, J., Hsueh, W., & Sowers, J. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.16225 · Cited by 1,411
Self-citationGrundy, S. M., Pasternak, R., Greenland, P., Smith, S., & Fuster, V. (1999) · Circulation · doi:10.1161/01.cir.100.13.1481 · Cited by 1,315
Rose, G. A., Stamler, J., Stamler, R., Elliott, P., Marmot, M. G., Pyörälä, K., Kesteloot, H., Joossens, J. V., Hansson, L. ‐., Mancia, G., et al. (1988) · Cited by 1,281
A general cardiovascular risk profile: The Framingham study
Kannel, W. B., McGee, D., & Gordon, T. (1976) · The American Journal of Cardiology · doi:10.1016/0002-9149(76)90061-8 · Cited by 1,189
Estacio, R. O., Jeffers, B. W., Hiatt, W. R., Biggerstaff, S. L., Gifford, N., & Schrier, R. W. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803053381003 · Cited by 1,166
Vasan, R. S., Larson, M. G., Leip, E. P., Kannel, W. B., & Levy, D. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06710-1 · Cited by 1,072
Stamler, R., Nissinen, A. M., Uusitalo, U. M., Rose, G., Pietinen, P., & Stamler, J. (1988) · Cited by 1,042
Mogensen, C. E., Neldam, S., Tikkanen, I., Oren, S., Viskoper, R., Watts, R. W., & Cooper, M. E. (2000) · BMJ · doi:10.1136/bmj.321.7274.1440 · Cited by 1,037
Neaton, J. D. (1993) · JAMA · doi:10.1001/jama.270.6.713 · Cited by 946
Agodoa, L. Y. (2001) · JAMA · doi:10.1001/jama.285.21.2719 · Cited by 944
Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension
Tuomilehto, J., Rastenyte, D., Birkenhäger, W. H., Thijs, L., Antikainen, R., Bulpitt, C. J., Fletcher, A. E., Forette, F., Goldhaber, A., Palatini, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400902 · Cited by 940
Stevens, V. J., Obarzanek, E., Cook, N. R., Lee, I.-M., Appel, L. J., Smith West, D., Milas, N. C., Mattfeldt-Beman, M., Belden, L., Bragg, C., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-1-200101020-00007 · Cited by 886
Psaty, B. M. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540330061036 · Cited by 875
Schrier, R. W., Estacio, R. O., Esler, A., & Mehler, P. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00213.x · Cited by 851
Tatti, P., Pahor, M., Byington, R. P., Mauro, P. D., Guarisco, R., Strollo, G., & Strollo, F. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.597 · Cited by 850
Law, C. M., & Shiell, A. W. (1996) · Journal of Hypertension · doi:10.1097/00004872-199608000-00002 · Cited by 727
Exercise standards. A statement for health professionals from the American Heart Association.
Fletcher, G. F., Froelicher, V. F., Hartley, L. H., Haskell, W. L., & Pollock, M. L. (1990) · Circulation · doi:10.1161/01.cir.82.6.2286 · Cited by 723
(2000) · PubMed · Cited by 691
Hillege, H. L., Janssen, W. M. T., Bak, A. A. A., Diercks, G. F. H., Grobbee, D. E., Crijns, H. J. G. M., Van Gilst, W. H., De Zeeuw, D., De Jong, P. E., & FOR THE PREVEND STUDY GROUP (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00833.x · Cited by 629
Sesso, H. D., Stampfer, M. J., Rosner, B., Hennekens, C. H., Gaziano, J. M., Manson, J. E., & Glynn, R. J. (2000) · Hypertension · doi:10.1161/01.hyp.36.5.801 · Cited by 599
Keane, W. F., & Eknoyan, G. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70442-7 · Cited by 591
Exner, D. V., Dries, D. L., Domanski, M. J., & Cohn, J. N. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441802 · Cited by 567
Exercise Standards: A Statement for Healthcare Professionals From the American Heart Association
Fletcher, G. F., Balady, G., Froelicher, V. F., Hartley, L. H., Haskell, W. L., & Pollock, M. L. (1995) · Circulation · doi:10.1161/01.cir.91.2.580 · Cited by 566
Eckel, R. H. (1997) · Circulation · doi:10.1161/01.cir.96.9.3248 · Cited by 513
Brenner, B. M., Cooper, M. E., & de Zeeuw, D. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00549-9 · Cited by 508
Treatment of Hypertension in Adults With Diabetes
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s80 · Cited by 497
Physician-Related Barriers to the Effective Management of Uncontrolled Hypertension
Oliveria, S. A., Lapuerta, P., McCarthy, B. D., L'Italien, G. J., Berlowitz, D. R., & Asch, S. M. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.4.413 · Cited by 479
Smith, S. C., Greenland, P., & Grundy, S. M. (2000) · Circulation · doi:10.1161/01.cir.101.1.111 · Cited by 465
Abernethy, D. R., & Schwartz, J. B. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911043411907 · Cited by 443
Hennekens, C. H., Dyken, M. L., & Fuster, V. (1997) · Circulation · doi:10.1161/01.cir.96.8.2751 · Cited by 435
Racial Profiling in Medical Research
Schwartz, R. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441810 · Cited by 430
Psaty, B. M., Furberg, C. D., Kuller, L. H., Cushman, M., Savage, P. J., Levine, D., O'Leary, D. H., Bryan, R. N., Anderson, M., & Lumley, T. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.9.1183 · Cited by 428
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.
Lopez, A., & Marantz, P. R. (1994) · PubMed · Cited by 424
Bakris, G. L., Copley, J. B., Vicknair, N., Sadler, R., & Leurgans, S. (1996) · Kidney International · doi:10.1038/ki.1996.480 · Cited by 417
Self-citationImportance of Systolic Blood Pressure in Older Americans
Izzo, J. L., Levy, D., & Black, H. R. (2000) · Hypertension · doi:10.1161/01.hyp.35.5.1021 · Cited by 401
Gibbons, R. J., Chatterjee, K., Daley, J., Douglas, J. S., Fihn, S. D., Gardin, J. M., Grunwald, M. A., Levy, D., Lytle, B. W., O’Rourke, R. A., et al. (1999) · Circulation · doi:10.1161/01.cir.99.21.2829 · Cited by 367
Self-citationElevated systolic blood pressure as a cardiovascular risk factor
Kannel, W. B. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00635-9 · Cited by 365
Normotensive Salt Sensitivity: Effects of Race and Dietary Potassium
Morris, R. C., Sebastian, A., Forman, A., Tanaka, M., & Schmidlin, O. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.18 · Cited by 328
He, J., & Whelton, P. K. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70312-1 · Cited by 325
Brown, N. J., Ray, W. A., Snowden, M., & Griffin, M. R. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90161-7 · Cited by 313
Rationale for Fixed-Dose Combinations in the Treatment of Hypertension: The Cycle Repeats
Sica, D. A. (2002) · Drugs · doi:10.2165/00003495-200262030-00003 · Cited by 293
Race and the Response to Adrenergic Blockade with Carvedilol in Patients with Chronic Heart Failure
Yancy, C. W., Fowler, M. B., Colucci, W. S., Gilbert, E. M., Bristow, M. R., Cohn, J. N., Lukas, M. A., Young, S. T., & Packer, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441803 · Cited by 288
Long-term Effects of Antihypertensive Agents on Proteinuria and Renal Function
Maki, D. D. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.10.1073 · Cited by 273
Appel, L. J., Espeland, M. A., Easter, L., Wilson, A. C., Folmar, S., & Lacy, C. R. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.5.685 · Cited by 273
Levine, R. S., Foster, J. E., Fullilove, R. E., Fullilove, M. T., Briggs, N. C., Hull, P. C., Husaini, B. A., & Hennekens, C. H. (2001) · Public Health Reports® · doi:10.1093/phr/116.5.474 · Cited by 262
Saunders, E. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00040031707020 · Cited by 252
Cirillo, M., Senigalliesi, L., Laurenzi, M., Alfieri, R., Stamler, J., Stamler, R., Panarelli, W., & De Santo, N. G. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.17.1933 · Cited by 228
Young-Hyman, D., Schlundt, D. G., Herman, L., De Luca, F., & Counts, D. (2001) · Diabetes Care · doi:10.2337/diacare.24.8.1359 · Cited by 225
Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients
Flack, J. M., Oparil, S., Pratt, J. H., Roniker, B., Garthwaite, S., Kleiman, J. H., Yang, Y., Krause, S. L., Workman, D., & Saunders, E. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00054-8 · Cited by 224
Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy
Lewis, J. B., Berl, T., Bain, R. P., Rohde, R. D., & Lewis, E. J. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70036-3 · Cited by 181
Cleland, J. G. F., Erhardt, L., Murray, G. D., et al. (1997) · PubMed · Cited by 168
Cushman, W. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.825 · Cited by 168
Antecedent Blood Pressure and Risk of Cardiovascular Disease: The Framingham Heart Study
Vasan, R. S., Massaro, J. M., Wilson, P. W. F., Seshadri, S. S., Wolf, P. A., Levy, D. A., & D’Agostino, R. B. (2002) · Circulation · doi:10.1161/hc0102.101774 · Cited by 158
Frishman, W. H., Bryzinski, B. S., Coulson, L. R., DeQuattro, V. L., Vlachakis, N. D., Mroczek, W. J., Dukart, G., Goldberg, J. D., Alemayehu, D., & Koury, K. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130048008 · Cited by 152
Effects of Blood Pressure Control on Progressive Renal Disease in Blacks and Whites
Hebert, L. A., Kusek, J. W., Greene, T., Agodoa, L. Y. C., Jones, C. A., Levey, A. S., Breyer, J. A., Faubert, P. F., ROLIN, H. A., & Wang, S.-R. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.428 · Cited by 152
Lewis, E. J., Hunsicker, L. G., & al, W. R. C. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00550-5 · Cited by 151
Bakris, G. L., Mangrum, A. J., Copley, J. B., Vicknair, N., & Sadler, R. (1997) · Hypertension · doi:10.1161/01.hyp.29.3.744 · Cited by 147
Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease.
He, J., & Whelton, P. K. (1999) · PubMed · Cited by 137
Gottlieb, S. S., McCarter, R., & Vogel, R. A. (1999) · Survey of Anesthesiology · doi:10.1097/00132586-199908000-00014 · Cited by 137
Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension
Pedrinelli, R., Dell’Omo, G., Bello, V. D., Pontremoli, R., & Mariani, M. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001316 · Cited by 135
High Blood Pressure and Diabetes Mellitus: Are All Antihypertensive Drugs Created Equal?
Grossman, E., Messerli, F. H., & Goldbourt, U. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.16.2447 · Cited by 132
Kotchen, T. A., & McCarron, D. A. (1998) · Circulation · doi:10.1161/01.cir.98.6.613 · Cited by 131
Messerli, F. H., Oparil, S., & Feng, Z. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01199-1 · Cited by 129
Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension
Kochar, M. S., Guthrie, R., Triscari, J., Kassler-Taub, K., & Reeves, R. A. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00053-9 · Cited by 123
McGill, J. B., & Reilly, P. A. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80072-2 · Cited by 118
Berenson, G. S., Voors, A. W., Webber, L. S., Dalferes, E. R., & Harsha, D. W. (1979) · Metabolism · doi:10.1016/0026-0495(79)90134-3 · Cited by 109
Parving, H., Hommel, E. E., Jensen, B. R., & Hansen, H. P. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00790.x · Cited by 104
Jensen, J., Feldt‐Rasmussen, B., Borch‐Johnsen, K., Clausen, P., Appleyard, M., & Jensen, G. (1997) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000459 · Cited by 100
Frishman, W. H., Ram, C. V. S., McMahon, F. G., Chrysant, S. G., Graff, A., Kupiec, J. W., & Hsu, H. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04027.x · Cited by 91
Increased sensitivity to bradykinin among African Americans
Gainer, J. V., Nadeau, J. H., Ryder, D., & Brown, N. J. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70151-3 · Cited by 89
Maximizing Cardiorenal Benefit in the Management of Hypertension: Achieve Blood Pressure Goals.
Bakris, G. L. (1999) · PubMed · Cited by 73
Effect of race on hypertension and antihypertensive therapy
Richardson, A. D., & Piepho, R. W. (2000) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp38075 · Cited by 71
Flack, J. M., Saunders, E., Gradman, A. H., Kraus, W. E., Lester, F. M., Pratt, J. H., Alderman, M. H., Green, S. A., Vargas, R., Espenshade, M., et al. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80101-6 · Cited by 65
Ames, R. P. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89233-8 · Cited by 65
Haywood, L. J. (1984) · American Heart Journal · doi:10.1016/0002-8703(84)90672-0 · Cited by 63
Elliott, W. J. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90155-1 · Cited by 60
Tenenbaum, A., Grossman, E., Shemesh, J., Fisman, E. Z., Nosrati, I. S., & Motro, M. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)00268-5 · Cited by 54
End-stage Renal Disease in Specific Ethnic and Racial Groups
Powers, D. R., & Wallin, J. D. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.7.793 · Cited by 53
Type 2 diabetes: RENAAL and IDNT–the emergence of new treatment options
Sica, D. A., & Bakris, G. L. (2002) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2002.00749.x · Cited by 49 · cited 1×
“Thus, an ARB may be considered at least as effective as an ACE inhibitor in the treatment of all patients with diabetic nephropathy who have higher than goal blood pressure.(124) The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study(121,122) included 9193 patients with high blood pressure and L…”
MethodFixed-dose combination vs monotherapy in hypertension: a meta-analysis evaluation
Hilleman, D. E., Ryschon, K. L., Sm, M., & Wurdeman, R. L. (1999) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000855 · Cited by 47
Pool, J. L., Cushman, W. C., Saini, R. K., Nwachuku, C. E., & Battikha, J. P. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(96)00323-8 · Cited by 45
Flack, J. M., Mensah, G. A., & Ferrario, C. M. (2000) · Current Medical Research and Opinion · doi:10.1185/030079900542867 · Cited by 45
The African American Study of Kidney Disease and Hypertension (AASK): New Findings
Sica, D. A., & Douglas, J. G. (2001) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2001.00474.x · Cited by 35
Self-citationCohen, E. G., & Soliman, A. M. S. (2001) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348940111000801 · Cited by 30
Salt intake and hypertensive renal injury in African-Americans a therapeutic perspective
Weir, M. R. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00048-t · Cited by 21
Fogari, R., Corea, L., Cardoni, O., Cosmi, F., Porcellati, C., Innocenti, P., Provvidenza, M., Timio, M., Bentivoglio, M., Bertocchi, F., et al. (1997) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199710000-00014 · Cited by 21
Hypertension in African Americans: a paradigm of metabolic disarray.
Weir, M. R., & Hanes, D. S. (1996) · PubMed · Cited by 15
Laing, C. M., & Unwin, R. J. (2000) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200009000-00005 · Cited by 5
Cited by
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., et al. (2006) · Stroke · doi:10.1161/01.str.0000223048.70103.f1 · Cited by 1,368
Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181fcb238 · Cited by 1,306
Williams, B., Poulter, N. R., Brown, M. J., Davis, M., McInnes, G. T., Potter, J. F., Sever, P. S., & McG Thom, S. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001683 · Cited by 1,272
Metadata
- Authors
- Douglas, J. G.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2003-03-10
- Volume
- 163
- Issue
- 5
- Pages
- 525
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2139692142
- Cited by
- 438
- References
- 123
- FWCI
- 29.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.